# Sanofi Consumer Healthcare India (NSE: SANOFICONR) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/SANOFICONR · Pivot · prices to 21 Oct 2026

Sanofi Consumer Healthcare India (NSE: SANOFICONR) closed at ₹3,362.80 on 21 Oct 2026. With a market capitalisation of ₹7,999 Cr, it ranks 628th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Drug Manufacturers - General.

At its last close the stock traded at 31× trailing earnings, against a return on equity of 62.5% in FY26. Over the past year the share price has fallen 25.8%. Its 52-week range is ₹3,359.00 (21 Oct 2026) to ₹5,255.00 (14 May 2026); the last close is 36.0% below the high. In Q1 FY27, the quarter ended 30 Jun 2026, revenue was ₹236 Cr (+6.7% year on year) and net profit ₹69 Cr (+13.3%), on a standalone basis. Promoters held 71.27% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹3,362.80 |
| Market cap | ₹7,999 Cr |
| P/E (trailing) | 31 |
| ROE | 62.5% (FY26) |
| ROCE | 75.4% (FY26) |
| Debt to equity | 0 |
| 52-week high | ₹5,255.00 (14 May 2026) |
| 52-week low | ₹3,359.00 (21 Oct 2026) |
| 1-year return | −25.8% |

## Quarterly results (₹ crore, standalone)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q1 FY27 | ₹236 Cr | +6.7% | ₹69 Cr | +13.3% | ₹29.87 |
| Q4 FY26 | ₹229 Cr | +32.8% | ₹68 Cr | +35.6% | ₹29.44 |
| Q3 FY26 | ₹251 Cr | +47.0% | ₹67 Cr | +50.1% | ₹28.87 |
| Q2 FY26 | ₹234 Cr | +46.3% | ₹63 Cr | +39.8% | ₹27.31 |
| Q1 FY26 | ₹221 Cr | +34.4% | ₹61 Cr | +109.3% | ₹26.36 |
| Q4 FY25 | ₹173 Cr | −18.3% | ₹50 Cr | −20.3% | ₹21.69 |
| Q3 FY25 | ₹171 Cr | −24.0% | ₹44 Cr | −34.8% | ₹19.25 |
| Q2 FY25 | ₹160 Cr | −24.0% | ₹45 Cr | −36.8% | ₹19.54 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY26 | ₹878 Cr | ₹240 Cr |
| FY25 | ₹725 Cr | ₹181 Cr |
| FY24 | ₹0 Cr | ₹0 Cr |
| FY24 | ₹555 Cr | ₹165 Cr |
| FY23 | ₹0 Cr | −₹0 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 71.27%
- Foreign institutions: 2.60%
- Domestic institutions: 17.86%
- Non-institutions: 8.27%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Yatharth Hospital & Trauma Care Services](https://app.pivotnow.in/stock/YATHARTH) | ₹968.00 | ₹9,327 Cr | 53.1 | — |
| [Healthcare Global Enterprises](https://app.pivotnow.in/stock/HCG) | ₹570.00 | ₹8,510 Cr | — | — |
| [Suven Life Sciences](https://app.pivotnow.in/stock/SUVEN) | ₹290.50 | ₹8,208 Cr | — | — |
| [Aarti Pharmalabs](https://app.pivotnow.in/stock/AARTIPHARM) | ₹835.00 | ₹7,572 Cr | 43.4 | — |
| [Thyrocare Technologies](https://app.pivotnow.in/stock/THYROCARE) | ₹469.95 | ₹7,480 Cr | 46.1 | — |
| [Supriya Lifescience](https://app.pivotnow.in/stock/SUPRIYA) | ₹872.50 | ₹7,022 Cr | 33.6 | — |

## Questions and answers

### What is the share price of Sanofi Consumer Healthcare India today?

Sanofi Consumer Healthcare India (NSE: SANOFICONR) last closed at ₹3,362.80 on 21 Oct 2026. Its 52-week high is ₹5,255.00 and its 52-week low is ₹3,359.00.

### What is the market cap of Sanofi Consumer Healthcare India?

Sanofi Consumer Healthcare India's market capitalisation is ₹7,999 Cr (₹7,999 Cr) at the 19 Oct 2026 close, ranking 628th among the NSE companies Pivot tracks.

### What is the P/E ratio of Sanofi Consumer Healthcare India?

Sanofi Consumer Healthcare India trades at a trailing P/E of 31. The median P/E of the 4 closest Pharma & Healthcare peers by market cap is 46.1.

### What is the ROE and ROCE of Sanofi Consumer Healthcare India?

Return on equity was 62.5% in FY26 and return on capital employed was 75.4% in FY26 (standalone figures).

### Is Sanofi Consumer Healthcare India a debt-free company?

Sanofi Consumer Healthcare India is close to debt-free: its debt-to-equity ratio was 0 in FY26.

### What were Sanofi Consumer Healthcare India's latest quarterly results?

For Q1 FY27 (quarter ended 30 Jun 2026), Sanofi Consumer Healthcare India reported revenue of ₹236 Cr, +6.7% year on year, and net profit of ₹69 Cr, +13.3% year on year.

### How has Sanofi Consumer Healthcare India stock performed over the last year?

Sanofi Consumer Healthcare India's share price has fallen 25.8% over the past year, −23.2% over three months and −13.7% over one month, to the 19 Oct 2026 close.

### What is the shareholding pattern of Sanofi Consumer Healthcare India?

As of 30 Jun 2026: promoters 71.27%, foreign institutions 2.60%, domestic institutions 17.86%, non-institutions 8.27%.

### Who are Sanofi Consumer Healthcare India's competitors?

The listed Pharma & Healthcare companies closest to Sanofi Consumer Healthcare India by market cap are Yatharth Hospital & Trauma Care Services, Healthcare Global Enterprises, Suven Life Sciences, Aarti Pharmalabs, Thyrocare Technologies and Supriya Lifescience.

### Is Sanofi Consumer Healthcare India a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Sanofi Consumer Healthcare India's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SANOFICONR against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.